PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.370
-0.020 (-0.46%)
At close: Mar 19, 2026, 4:00 PM EDT
4.370
0.00 (0.00%)
After-hours: Mar 19, 2026, 5:51 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $79.55 million as of March 19, 2026. Its market cap has increased by 167.80% in one year.
Market Cap
79.55M
Enterprise Value
69.41M
1-Year Change
167.80%
Ranking
Category
Stock Price
$4.37
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $79.55M, a decrease of -3.50%. That is a compound annual growth rate of -0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 83.78M | 16.04% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 88.31M |
| aTyr Pharma | 87.71M |
| Champions Oncology | 86.79M |
| Spruce Biosciences | 83.63M |
| PMV Pharmaceuticals | 83.19M |
| Seres Therapeutics | 83.02M |
| iBio, Inc. | 82.56M |
| Pliant Therapeutics | 81.11M |